Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 26794 [2016-10422]
Download as PDF
<![CDATA[
26794
Federal Register / Vol. 81, No. 86 / Wednesday, May 4, 2016 / Notices
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than May 31, 2016.
A. Federal Reserve Bank of
Minneapolis (Jacquelyn K. Brunmeier,
Assistant Vice President) 90 Hennepin
Avenue, Minneapolis, Minnesota
55480–0291:
1. Ascent Bancorp, Helena, Montana;
to become a bank holding company by
acquiring 100 percent of the voting
shares of First Security Bank of Helena,
Helena, Montana.
Board of Governors of the Federal Reserve
System, April 29, 2016.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2016–10432 Filed 5–3–16; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention announces the
following meeting of the
aforementioned committee:
Time and Date
asabaliauskas on DSK3SPTVN1PROD with NOTICES
11:00 a.m.–2:00 p.m. EDT, Wednesday,
May 25, 2016
Place: Audio Conference Call via FTS
Conferencing.
Status: Open to the public. The public
is welcome to submit written comments
in advance of the meeting, to the contact
person below. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. The public is also welcome to
listen to the meeting by joining the
teleconference at the USA toll-free, dialin number, 1–866–659–0537 and the
passcode is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
VerDate Sep<11>2014
18:44 May 03, 2016
Jkt 238001
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines,
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, rechartered on March 22, 2016
pursuant to Executive Order 13708, and
will expire on September 30, 2017.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters for Discussion: The agenda for
the conference call includes: Work
Group and Subcommittee Reports; SEC
Petitions Update for the August 2016
Advisory Board Meeting; Plans for the
August 2016 Advisory Board Meeting;
and Advisory Board Correspondence.
Contact Person for More Information:
Theodore M. Katz, M.P.A., Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Rd. NE., Mailstop: E–20, Atlanta,
GA 30333, Telephone (513) 533–6800,
Toll Free 1–800–CDC–INFO, Email
ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2016–10420 Filed 5–3–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Health Promotion and Disease
Prevention Research Centers: Special
Interest Project Competitive
Supplements (SIPS), DP16–006, initial
review.
Summary: This document corrects a
notice that was published in the Federal
Register on April 21, 2016, Volume 81,
Number 77, page 23497. This meeting is
cancelled in its entirety.
Contact Person for More Information:
Brenda Colley Gilbert, Ph.D., M.S.P.H.,
Director, Extramural Research Program
Operations and Services, CDC, 4770
Buford Highway NE., Mailstop F–80,
Atlanta, Georgia 30341, Telephone:
(770) 488–6295, BJC4@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
[FR Doc. 2016–10422 Filed 5–3–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Nominations of
Candidates To Serve on the Breast and
Cervical Cancer Early Detection and
Control Advisory Committee
(BCCEDCAC)
The Centers for Disease Control and
Prevention (CDC) is soliciting
E:\FR\FM\04MYN1.SGM
04MYN1
]]>Agencies
[Federal Register Volume 81, Number 86 (Wednesday, May 4, 2016)]
[Notices]
[Page 26794]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-10422]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Health Promotion and Disease
Prevention Research Centers: Special Interest Project Competitive
Supplements (SIPS), DP16-006, initial review.
Summary: This document corrects a notice that was published in the
Federal Register on April 21, 2016, Volume 81, Number 77, page 23497.
This meeting is cancelled in its entirety.
Contact Person for More Information: Brenda Colley Gilbert, Ph.D.,
M.S.P.H., Director, Extramural Research Program Operations and
Services, CDC, 4770 Buford Highway NE., Mailstop F-80, Atlanta, Georgia
30341, Telephone: (770) 488-6295, BJC4@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office Centers for
Disease Control and Prevention.
[FR Doc. 2016-10422 Filed 5-3-16; 8:45 am]
BILLING CODE 4163-18-P
